Skip to content

Syncona Portfolio Ltd

Follow

13F filer, CIK 1725042, St Peter Port, Guernsey, United Kingdom

Syncona Portfolio Ltd reported $26,370,531 across 2 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-07.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-25-004190

Period
2025-03-31
Reported value
$26.4M
Holdings
2
Top 10 weight
100%
New
0
Sold out
1

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ACHILLES THERAPEUTICS PL-ADRexited-11,086,909-$12.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0000950123-25-004190, largest first. % of portfolio is the value over $26,370,531, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 18,554,624 shares; 2024Q4: 16,640,720 shares; 2025Q1: 16,640,720 shares 16,640,720$25.8M97.81%0Timeline
IPSCCENTURY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,213,056 shares; 2024Q4: 1,213,056 shares; 2025Q1: 1,213,056 shares 1,213,056$577K2.19%0Timeline

Sold out in Q1 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ACHILLES THERAPEUTICS PL-ADRACHILLES THERAPEUTICS PL-ADR11,086,909$12.6Mshares

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-25-004190 base2025-05-07acceptance time not in the bulk data set